PureTech Health PLC Holding(s) in Company (9994H)

TIDMPRTC

RNS Number : 9994H

PureTech Health PLC

13 June 2017

 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 
 
 
 
 1. Identity of the issuer or 
  the underlying issuer of existing                         PURETECH HEALTH PLC 
  shares to which voting rights 
  are attached: ii 
-------------------------------------------------------  --------------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
------------------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights                    Yes 
---------------------------------------------------------  ------------------------------------------- 
 An acquisition or disposal of qualifying financial              No 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
---------------------------------------------------------  ------------------------------------------- 
 An acquisition or disposal of instruments with                  No 
  similar economic effect to qualifying financial 
  instruments 
---------------------------------------------------------  ------------------------------------------- 
 An event changing the breakdown of voting rights                No 
---------------------------------------------------------  ------------------------------------------- 
 Other (please specify):                                         No 
---------------------------------------------------------  ------------------------------------------- 
 
   3. Full name of person(s) 
   subject to the notification                          Recordati SA Chemical and Pharmaceutical 
   obligation: iii                                      Company 
---------------------------------------------------  ------------------------------------------------- 
 
    4. Full name of shareholder(s) 
    (if different from 3.):iv 
---------------------------------------------------  ------------------------------------------------- 
 5. Date of the transaction 
  and date on which the threshold                       12 June 2017 
  is crossed or reached: v 
---------------------------------------------------  ------------------------------------------------- 
 6. Date on which issuer notified:                    13 June 2017 
---------------------------------------------------  ------------------------------------------------- 
 7. Threshold(s) that is/are 
  crossed or reached: vi, vii                           Below 3% 
---------------------------------------------------  ------------------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares viii, ix 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                   Resulting situation after the 
  of shares      to the triggering                    triggering transaction 
                 transaction 
  if possible 
  using the 
  ISIN CODE 
-------------  -----------------------------------  ------------------------------------------------------------------ 
                Number             Number            Number          Number of voting         % of voting 
                of Shares           of Voting         of shares       rights                   rights x 
                                    Rights 
-------------  -----------------  ----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     xi          xii 
-------------      -------------    ------------    --------------  ---------  ------------  ------------  ----------- 
 GB00BY2Z0H74   9,554,140          9,554,140         0               0          0             0%            0 
-------------  -----------------  ----------------  --------------  ---------  ------------  ------------  ----------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration       Exercise/ Conversion              Number of voting           % of voting 
 financial           date xiii        Period xiv                        rights that                rights 
 instrument                                                             may be acquired 
                                                                        if the instrument 
                                                                        is exercised/ 
                                                                        converted. 
-----------------  ---------------  --------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments 
  xv, xvi 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise         Expiration      Exercise/         Number of voting           % of voting 
 financial         price           date xvii       Conversion         rights instrument          rights xix, 
 instrument                                        period             refers to                  xx 
                                                   xviii 
---------------  ---------------  --------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  ---------------  --------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 0                                                     0% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the financial instruments are effectively 
  held, if applicable: xxi 
------------------------------------------------------------------------------------------------------ 
 
 
 Proxy Voting: 
------------------------------------------------------------------------------------------------------ 
 10. Name of the proxy holder: 
-----------------------------------------------------------------  ----------------------------------- 
 11. Number of voting rights proxy 
  holder will cease to hold: 
-----------------------------------------------------------------  ----------------------------------- 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
-----------------------------------------------------------------  ----------------------------------- 
 
                                                                    This transfer of voting rights 
   13. Additional information:                                      relates to a merger by absorption 
                                                                    of Recordati SA Chemical and 
                                                                    Pharmaceutical Company into 
                                                                    Recordati S.p.A, with Recordati 
                                                                    S.p.A as the surviving entity. 
-----------------------------------------------------------------  ----------------------------------- 
 14. Contact name: 
                                                                      Silvia Signoretti 
-----------------------------------------------------------------  ----------------------------------- 
 
 15. Contact telephone number:                                        [phone] 
-----------------------------------------------------------------  ----------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFJMFTMBABBPR

(END) Dow Jones Newswires

June 13, 2017 13:01 ET (17:01 GMT)